Preclinical and Nonclinical Vaccine Testing
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract involves conducting preclinical and nonclinical vaccine testing through animal studies and in vitro assays aimed at evaluating immunogenicity, cross-reactivity, and protective efficacy against pandemic influenza strains. The scope includes performing challenge studies and analyzing immune responses to assess vaccine candidates. The work is to be carried out primarily in Washington, with the Department of Health and Human Services, specifically under BARDA - ASPR / DAAPPO / BARDA DCMA, as the contracting agency. The contract is a subcontract opportunity under NAICS code 541715, focusing on research and development in the physical, engineering, and life sciences. The solicitation was posted on June 3, 2026, and the response deadline is July 15, 2026, with no set-aside restrictions indicated. This opportunity requires specialized capabilities in vaccine immunology and infectious disease research to support pandemic preparedness efforts.
General Info
Agency
NAICS
Place of Performance
Washington, DC, 20024, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
